🇺🇸 FDA
Patent

US 10214726

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

granted A61KA61K2039/585A61K2239/56

Quick answer

US patent 10214726 (Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/585, A61K2239/56, A61K35/12, A61K35/17